The Patent Finder

Kracie Holdings, Ltd.

10 patents currently held · Updated Nov 21, 2026
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
2
Ending by 2030
Oct 2028
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Jan 7, 2027
    The maintenance fee for Burdock Fruit Extract Containing Arctigenin and Method for Producing Same (US 9,072,718) comes due Jan 7, 2027. Unpaid by Jul 7, 2027, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

Nothing was recorded against this company's patents in the last 90 days.

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.

Showing 1 to 10 of 10

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 7,582,599Detergent composition comprising a mixture of two anionic, a nonionic, and an amphoteric surfactant
In force
 · USPTO record
In forceUSPTO record
US 9,586,921Burdock Fruit Extract Containing Arctigenin at High Content and Process for Producing Same
In force
 · High confidence
In forceHigh confidence
US 9,072,718Burdock Fruit Extract Containing Arctigenin and Method for Producing Same
In force
 · High confidence
In forceHigh confidence
US D805,396Package
In force
 · USPTO record
In forceUSPTO record
US D805,397Package
In force
 · USPTO record
In forceUSPTO record
US D807,194Package
In force
 · USPTO record
In forceUSPTO record
US 9,700,572Anti-Cancer Agent
In force
 · High confidence
In forceHigh confidence
US 9,907,852Anticancer Agent and Side-Effect-Alleviating Agent
In force
 · High confidence
In forceHigh confidence
US 11,376,235Inhibitor of inflammasome activation
In force
 · USPTO record
In forceUSPTO record
US 11,554,133Bile acid synthesis promoter, composition for promoting bile acid synthesis and food composition for promoting bile acid synthesis
In force
 · USPTO record
In forceUSPTO record

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

1 no status recorded

List them

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited